Literature DB >> 29602951

A latent ability to persist: differentiation in Toxoplasma gondii.

Victoria Jeffers1, Zoi Tampaki2, Kami Kim2,3, William J Sullivan4,5.   

Abstract

A critical factor in the transmission and pathogenesis of Toxoplasma gondii is the ability to convert from an acute disease-causing, proliferative stage (tachyzoite), to a chronic, dormant stage (bradyzoite). The conversion of the tachyzoite-containing parasitophorous vacuole membrane into the less permeable bradyzoite cyst wall allows the parasite to persist for years within the host to maximize transmissibility to both primary (felids) and secondary (virtually all other warm-blooded vertebrates) hosts. This review presents our current understanding of the latent stage, including the factors that are important in bradyzoite induction and maintenance. Also discussed are the recent studies that have begun to unravel the mechanisms behind stage switching.

Entities:  

Keywords:  Bradyzoite; Differentiation; Encystation; Epigenetics; Gene regulation; Immunity; Latency; Tachyzoite; Toxoplasma; Toxoplasmosis

Mesh:

Year:  2018        PMID: 29602951      PMCID: PMC5988958          DOI: 10.1007/s00018-018-2808-x

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  193 in total

1.  Disruption of the Toxoplasma gondii bradyzoite-specific gene BAG1 decreases in vivo cyst formation.

Authors:  Y W Zhang; K Kim; Y F Ma; M Wittner; H B Tanowitz; L M Weiss
Journal:  Mol Microbiol       Date:  1999-01       Impact factor: 3.501

2.  Toxoplasma gondii: identification of a developmentally regulated family of genes related to SAG2.

Authors:  C Lekutis; D J Ferguson; J C Boothroyd
Journal:  Exp Parasitol       Date:  2000-10       Impact factor: 2.011

3.  NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.

Authors:  Crescent L Combe; Tyler J Curiel; Magali M Moretto; Imtiaz A Khan
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Characterization of bradyzoite-specific antigens of Toxoplasma gondii.

Authors:  S Tomavo; B Fortier; M Soete; C Ansel; D Camus; J F Dubremetz
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

5.  In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection.

Authors:  T M Scharton-Kersten; T A Wynn; E Y Denkers; S Bala; E Grunvald; S Hieny; R T Gazzinelli; A Sher
Journal:  J Immunol       Date:  1996-11-01       Impact factor: 5.422

6.  A cell culture system for study of the development of Toxoplasma gondii bradyzoites.

Authors:  L M Weiss; D Laplace; P M Takvorian; H B Tanowitz; A Cali; M Wittner
Journal:  J Eukaryot Microbiol       Date:  1995 Mar-Apr       Impact factor: 3.346

7.  Isolation of developmentally regulated genes from Toxoplasma gondii by a gene trap with the positive and negative selectable marker hypoxanthine-xanthine-guanine phosphoribosyltransferase.

Authors:  L J Knoll; J C Boothroyd
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

8.  Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

Authors:  R T Gazzinelli; S Hieny; T A Wynn; S Wolf; A Sher
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

9.  Effect of the strain of Toxoplasma gondii on the development of toxoplasmic encephalitis in mice treated with antibody to interferon-gamma.

Authors:  Y Suzuki; K Joh
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

10.  Endogenous tumor necrosis factor alpha is required for enhanced antimicrobial activity against Toxoplasma gondii and Listeria monocytogenes in recombinant gamma interferon-treated mice.

Authors:  J A Langermans; M E van der Hulst; P H Nibbering; R van Furth
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

View more
  35 in total

Review 1.  The RESTRICTION checkpoint: a window of opportunity governing developmental transitions in Toxoplasma gondii.

Authors:  Anthony P Sinai; Elena S Suvorova
Journal:  Curr Opin Microbiol       Date:  2020-10-13       Impact factor: 7.934

2.  One gene to rule them all in a chronic brain infection.

Authors:  Eva-Maria Frickel
Journal:  Nature       Date:  2020-03       Impact factor: 49.962

3.  Chronic Toxoplasma gondii infection enhances susceptibility to colitis.

Authors:  Iti Saraav; Luisa Cervantes-Barragan; Philipp Olias; Yong Fu; Qiuling Wang; Leran Wang; Yi Wang; Matthias Mack; Megan T Baldridge; Thaddeus Stappenbeck; Marco Colonna; L David Sibley
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-07       Impact factor: 11.205

4.  Restriction Checkpoint Controls Bradyzoite Development in Toxoplasma gondii.

Authors:  Anatoli V Naumov; Chengqi Wang; Dale Chaput; Li-Min Ting; Carmelo A Alvarez; Thomas Keller; Ahmed Ramadan; Michael W White; Kami Kim; Elena S Suvorova
Journal:  Microbiol Spectr       Date:  2022-06-02

5.  Acute toxoplasmosis and pox-viral dermatitis in a juvenile bald eagle (Haliaeetus leucocephalus) in New Brunswick, Canada.

Authors:  Laura Bourque; Spencer J Greenwood; Megan E B Jones
Journal:  Can Vet J       Date:  2020-08       Impact factor: 1.008

6.  A novel GCN5b lysine acetyltransferase complex associates with distinct transcription factors in the protozoan parasite Toxoplasma gondii.

Authors:  Michael T Harris; Victoria Jeffers; Jennifer Martynowicz; Jason D True; Amber L Mosley; William J Sullivan
Journal:  Mol Biochem Parasitol       Date:  2019-08-02       Impact factor: 1.759

Review 7.  Toxoplasma gondii infection and its implications within the central nervous system.

Authors:  Sumit K Matta; Nicholas Rinkenberger; Ildiko R Dunay; L David Sibley
Journal:  Nat Rev Microbiol       Date:  2021-02-24       Impact factor: 60.633

8.  Peptidylarginine Deiminase (PAD) and Post-Translational Protein Deimination-Novel Insights into Alveolata Metabolism, Epigenetic Regulation and Host-Pathogen Interactions.

Authors:  Árni Kristmundsson; Ásthildur Erlingsdóttir; Sigrun Lange
Journal:  Biology (Basel)       Date:  2021-02-26

Review 9.  Protozoan persister-like cells and drug treatment failure.

Authors:  Michael P Barrett; Dennis E Kyle; L David Sibley; Joshua B Radke; Rick L Tarleton
Journal:  Nat Rev Microbiol       Date:  2019-08-23       Impact factor: 60.633

10.  Toxoplasma gondii secreted effectors co-opt host repressor complexes to inhibit necroptosis.

Authors:  Alex Rosenberg; L David Sibley
Journal:  Cell Host Microbe       Date:  2021-05-26       Impact factor: 31.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.